MyFinsight
Home
Blog
About
Comprehensive (loss) income
-$18,081K
(-268.73%↓ Y/Y)
Diagnostic Test Third Party
Insurance
$94,726K
Diagnostic Test
Institutional Customers
$16,118K
Diagnostic Test Self Pay
$1,042K
Net (loss) income
-$17,740K
(-264.12%↓ Y/Y)
Unrealized gain related to
available for sale...
-$341K
(-266.67%↓ Y/Y)
Income tax benefit
(expense)
-$518K
(-110.57%↓ Y/Y)
Diagnostic Test
$111,886K
Product And Service
Other
$2,554K
(loss) income before
income taxes
-$18,258K
(-272.85%↓ Y/Y)
Total revenue
$114,440K
(11.44%↑ Y/Y)
(loss) income from
operations
-$17,455K
(-294.81%↓ Y/Y)
Total non-operating
(expense) income, net
-$803K
(-150.09%↓ Y/Y)
Gross profit
$78,238K
(10.35%↑ Y/Y)
Change in fair value of
financial liabilities
$220K
(-89.91%↓ Y/Y)
Other income
(expense), net
$162K
(-32.22%↓ Y/Y)
Cost of services
$36,202K
(13.88%↑ Y/Y)
Selling, general and
administrative
$76,037K
Interest expense, net
-$1,185K
(-45.04%↓ Y/Y)
Research and development
$19,656K
(30.35%↑ Y/Y)
Back
Back
Income Statement
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (WGS)
source: myfinsight.com